Veterinary Vaccines Market to Grow at 7.2% CAGR Through 2032

Introduction

The Global Veterinary Vaccines Market is set to grow significantly, with its value projected to reach USD 22.1 billion by 2032, up from USD 11.2 billion in 2022. This growth, at a CAGR of 7.2% from 2022 to 2032, is driven by several factors. First, there is an increasing focus on animal health and welfare, which boosts the demand for effective vaccines to prevent diseases in livestock and pets. Additionally, the rise in pet ownership and growing awareness among pet owners about preventive care contribute to the market’s expansion.

Technological advancements in vaccine development have also enhanced the efficacy and safety of veterinary vaccines. The use of recombinant DNA technology and novel adjuvants allows for the production of more targeted vaccines that effectively address specific pathogens in animals. These innovations are crucial in the fight against diseases and ensure the health and productivity of livestock. This technological progress supports the creation of vaccines tailored to complex diseases, improving health outcomes across various animal populations.

Government initiatives and policies supporting animal health are significant growth drivers. For example, the U.S. Department of Agriculture (USDA) and international bodies regulate and approve veterinary vaccines, ensuring their safety and effectiveness. Such regulatory support facilitates the introduction of new vaccines into the market. The rising incidence of zoonotic diseases, which can be transmitted from animals to humans, also underscores the importance of vaccines in maintaining public health. Consequently, there has been increased investment in research and development to create vaccines that prevent these diseases.

The market has seen recent developments driven by technological advancements and increased awareness of animal health. In 2020, HIPRA launched GUMBOHATCH, an innovative vaccine for Infectious Bursal Disease in broiler chickens. This development represents a step forward in poultry health. Similarly, Hester Biosciences developed a new Brucella vaccine aimed at providing lifelong immunity for cattle. Zoetis also received FDA authorization for Simparica, a chewable flea and tick prevention product for cattle, addressing common parasitic challenges.

The emergence of mRNA technology in veterinary medicine offers promising avenues for preventing diseases that traditional vaccines may not effectively address. For example, Merck’s Sequivity, an saRNA vaccine for swine flu, highlights the potential for cutting-edge vaccines to provide targeted protection against specific pathogens. Additionally, the development of second-generation vaccines using recombinant protein technologies is gaining momentum. These vaccines offer a safer and more targeted approach, particularly for complex diseases affecting livestock. The adoption of novel adjuvants to enhance the immune response further supports the effectiveness of these new vaccine formulations.

Key Takeaways

• Market Size: The global veterinary vaccines market is set to grow significantly, with its value projected to reach USD 22.1 billion by 2032.
• Market Growth:The global veterinary vaccines market is Growing with CAGR of 7.2% from 2022 to 2032.
• Technological Developments: Ongoing advancements in veterinary vaccines, including DNA and recombinant vaccines, enhance stability and ease of administration.
• Recombinant Vaccines: Expected to lead growth due to their safety and efficacy, with manufacturers investing in higher-quality production.
• Companion Animals: This is the dominant market segment, driven by rising pet ownership and animal adoption worldwide.
• Parenteral Administration: The leading route for vaccine delivery includes intramuscular, subcutaneous, and intradermal options.
• Disease Indication: Porcine reproductive and respiratory syndrome holds the largest market share due to its high prevalence.
• Distribution Channels: Veterinary clinics lead distribution, with pharmacies and drug stores also showing growth.
• Market Drivers: Rising awareness and advanced vaccine products propel the market, addressing zoonotic diseases.
• Regional Analysis: North America dominates the market due to the prevalence of zoonotic diseases and favorable compensation programs.

Veterinary Vaccines Statistics

• Nationwide Vaccination Rates for Dogs:
  • Leptospirosis: 63.4% of dogs with core vaccinations are current, with a median clinic rate of 70.5%.
  • Bordetella: 64.6% of dogs are vaccinated, with the highest rates in the South-Central and Southeast regions.
  • Canine Influenza: The median clinic rate is 4.8%, with notable increases in Maryland and Illinois.
  • Borreliosis: In Lyme-endemic states, 47.9% of dogs are vaccinated, with varying rates across states.
• Feline Vaccination:
  • Feline Leukemia (FeLV): 32.8% of adult cats are current on vaccinations, with the highest rates in Oklahoma and Louisiana.
• Vaccination Protocols and Practices:
  • Clinics with a 1-year core vaccine protocol exhibit higher vaccination rates for leptospirosis, Bordetella, and FeLV compared to those with 3-year intervals.
  • Variation in non-core vaccination rates across clinics and states suggests external factors influence vaccine recommendations.
• Commercial Vaccine Formulations:
  • Species Distribution: Avian vaccines constitute 42.6%, bovine vaccines 35.4%, and fish vaccines 22% of the market from 2021 to 2022.
  • Vaccine Types: Inactivated vaccines make up 58.9%, live vaccines 37.6%, and the remainder includes recombinant, genetically modified, and DNA vaccines.
  • Technology Use: Traditional methods dominate with 96.6% usage in vaccine formulations.
  • Polyvalent Formulations: Common in cattle (76.9%) and poultry (56%), making up 63.2% of the market.
• Adjuvants in Vaccine Production:
  • Aluminum compounds are utilized in 25% of bovine vaccines.
  • Mineral oil is used in 53.5% of fish vaccines, reflecting cost-effective choices.
• Foot and Mouth Disease (FMD) Vaccination Drive in India:
  • Coverage: The campaign vaccinated approximately 240 million cattle and buffaloes.
  • Target: Aimed at 258 million cattle and buffaloes, achieving over 95% coverage.
  • Government Support: The program is fully funded by the Government of India, covering vaccine procurement and necessary infrastructure.

Emerging Trends

• Recombinant and DNA Vaccines: Recombinant and DNA vaccines are at the forefront of vaccine development due to their ability to provide stable and targeted immune responses. Recombinant vaccines utilize genetically modified organisms to produce antigens that stimulate an immune response without causing disease. This approach allows for the creation of vaccines that are specific to particular pathogens, which can be especially beneficial in veterinary medicine. DNA vaccines, on the other hand, involve introducing a piece of the pathogen’s genetic material directly into the animal’s cells, prompting the immune system to recognize and respond to the pathogen. Both technologies offer advantages such as stability, ease of production, and the potential for long-lasting immunity. These vaccines are being explored for various animal diseases, from bacterial infections to viral diseases, improving prevention and control measures in animal populations.
• mRNA Technology: Following its success in human medicine, mRNA vaccine technology is now being adapted for animal health. mRNA vaccines work by using messenger RNA to instruct cells to produce proteins that elicit an immune response. This technology allows for rapid development and deployment of vaccines, which is crucial for responding to emerging and re-emerging pathogens. In veterinary medicine, mRNA vaccines have the potential to provide quick protection against diseases like avian influenza, African swine fever, and other critical animal diseases. The flexibility of mRNA technology enables the rapid adjustment of vaccines in response to evolving pathogens, potentially transforming the way animal health issues are managed.
• Viral Vector Vaccines: Viral vector vaccines are gaining popularity for their ability to induce robust immune responses while minimizing the risk of disease. These vaccines use a modified, harmless virus to deliver genetic material from a pathogen into host cells, prompting the immune system to mount a defense against the pathogen. The viral vector itself does not cause illness but carries the necessary genetic instructions to stimulate an immune response. This approach has shown promise in vaccinating animals against a variety of diseases, including West Nile virus in horses and canine parvovirus. The strength of the immune response generated by viral vector vaccines and their safety profile make them a valuable tool in veterinary vaccine development.
• Combination Vaccines: Combination vaccines, which protect against multiple diseases with a single injection, are becoming increasingly popular due to their convenience and efficacy. By combining vaccines for several pathogens into one shot, these vaccines reduce the number of injections required, which can decrease stress and discomfort for animals. Combination vaccines are particularly beneficial for diseases that often occur together or where multiple vaccinations are needed over a short period. For example, vaccines that combine protection against diseases such as canine distemper, parvovirus, and adenovirus help streamline the vaccination process and ensure comprehensive coverage. This approach not only simplifies vaccine administration but also improves compliance and overall health management for animals.
• Digital Health Integration: The integration of digital health tools into veterinary practice is revolutionizing vaccine management and monitoring. Wearable devices, mobile apps, and electronic health records are being used to track vaccination schedules, monitor animal health, and manage vaccine inventory. Digital tools help ensure that animals receive timely vaccinations and adhere to recommended schedules. These technologies also provide valuable data for assessing vaccine efficacy and tracking potential side effects. By leveraging digital health solutions, veterinarians can enhance vaccine compliance, optimize health management strategies, and improve overall outcomes for animals.
• One Health Approach: The One Health approach emphasizes the interconnectedness of human, animal, and environmental health. This holistic perspective drives the development of vaccines that not only protect animals but also prevent the transmission of zoonotic diseases—those that can be transmitted between animals and humans. For example, vaccines for rabies and leptospirosis are crucial in preventing diseases that can cross species barriers. By addressing the health of animals in the context of their interaction with human populations and the environment, the One Health approach aims to improve public health outcomes and reduce the risk of disease outbreaks.
• Global Vaccination Campaigns: International collaborations and global vaccination campaigns are critical for improving vaccination rates and controlling animal diseases in developing countries. Diseases like rabies, foot-and-mouth disease, and Newcastle disease pose significant health and economic threats, particularly in regions with limited access to veterinary services. Global efforts focus on increasing vaccine availability, improving distribution networks, and conducting vaccination drives to reach underserved populations. These campaigns often involve partnerships between governments, non-governmental organizations, and veterinary groups to enhance vaccination coverage and reduce the incidence of debilitating diseases.
• Therapeutic Vaccines: Therapeutic vaccines represent a new frontier in veterinary medicine, offering the potential to treat existing conditions rather than just preventing them. For example, vaccines targeting cancer in pets are being developed to stimulate the immune system to recognize and attack cancer cells. These vaccines work by introducing tumor-specific antigens or immune-modulating factors that enhance the body’s ability to fight cancer. The development of therapeutic vaccines for conditions such as canine melanoma and feline leukemia holds promise for improving treatment options and outcomes for pets with serious diseases.
• Regulatory Support: Streamlined regulatory processes are crucial for accelerating the approval and availability of new vaccines in veterinary medicine. Regulatory agencies are implementing measures to facilitate the development and deployment of innovative vaccines, including faster review times and more flexible approval pathways. These efforts aim to support the introduction of new technologies and address emerging health threats effectively. By providing a supportive regulatory environment, agencies encourage innovation and ensure that new vaccines are both safe and effective, ultimately benefiting animal health and welfare.

Use Cases

• Prevention of Infectious Diseases: Vaccines are a cornerstone in safeguarding livestock from infectious diseases that pose significant threats to animal health and agricultural productivity. Diseases such as foot-and-mouth disease (FMD) and avian influenza can cause severe outbreaks, leading to high morbidity and mortality rates among livestock. The use of vaccines helps to create a protective immunity in animals, thereby reducing the incidence of these diseases. By preventing outbreaks, vaccines also mitigate the risk of disease transmission within herds and flocks, leading to a healthier animal population. This proactive approach not only protects animal welfare but also shields farmers from the devastating economic losses associated with disease outbreaks.
• Enhancing Livestock Productivity: Disease prevention through vaccination directly impacts livestock productivity. Infectious diseases can impair growth rates, reduce feed conversion efficiency, and decrease milk production in dairy animals. For example, vaccines against bovine respiratory disease (BRD) help maintain optimal growth rates and milk yields by preventing respiratory infections that can compromise the health and productivity of cattle. By ensuring that livestock remain healthy and productive, vaccines contribute significantly to the agricultural economy, supporting food security and farm profitability. This increased productivity is vital for meeting global food demands and sustaining the livelihoods of farmers.
• Supporting Public Health: Vaccines are instrumental in controlling zoonotic diseases—those transmitted from animals to humans. Diseases like rabies, which can be fatal if not promptly treated, are controlled through vaccination programs for pets and wildlife. Vaccination not only protects animals but also reduces the risk of disease transmission to humans, contributing to public health safety. For instance, mass vaccination campaigns in dogs have been effective in reducing the incidence of rabies in many regions, preventing human cases and deaths. By controlling zoonotic diseases, vaccines play a crucial role in safeguarding human health and reducing healthcare costs associated with treating these diseases.
• Reducing Antibiotic Use: The prevention of infectious diseases through vaccination is a key strategy in reducing the reliance on antibiotics in livestock production. Overuse and misuse of antibiotics in animal farming can lead to the development of antimicrobial resistance (AMR), a growing global health concern. Vaccines reduce the incidence of infections, thereby decreasing the need for therapeutic antibiotics. This reduction in antibiotic use helps to preserve the effectiveness of these critical medications for both human and animal health. Additionally, vaccination programs contribute to more sustainable farming practices by minimizing the environmental impact of antibiotic residues.
• Pet Health and Longevity: Vaccines are essential for maintaining the health and well-being of pets, protecting them from common and potentially life-threatening diseases. For instance, vaccines against distemper, parvovirus, and feline leukemia are crucial for preventing these serious illnesses in dogs and cats. By preventing these diseases, vaccines help ensure that pets live longer, healthier lives. Regular vaccination also reduces the risk of disease outbreaks within pet populations, promoting overall community health. The extension of pet lifespan and improved quality of life are significant benefits of effective vaccination programs.
• Aquaculture Industry: In the aquaculture industry, vaccines play a vital role in preventing bacterial and viral infections that can affect fish health and production. Diseases such as vibriosis and infectious salmon anemia (ISA) can lead to significant losses in fish farms, impacting both fish welfare and economic viability. Vaccines designed for fish are used to protect against these pathogens, ensuring the production of high-quality, disease-free fish. By reducing the incidence of disease, vaccines help maintain the sustainability of aquaculture operations, supporting global seafood supply and economic stability in the industry.
• Wildlife Conservation: Vaccination programs are increasingly being employed in wildlife conservation efforts to control diseases that threaten endangered species. For example, vaccination against rabies has been used in wildlife populations to protect species such as foxes and bats. By controlling disease outbreaks in wildlife, vaccination programs contribute to the preservation of biodiversity and the survival of endangered species. These efforts are essential for maintaining healthy ecosystems and preventing the extinction of vulnerable animal populations.
• Economic Benefits to Farmers: Vaccines provide significant economic benefits to farmers by reducing the financial impact of disease outbreaks. By preventing diseases, vaccines lower veterinary costs, decrease livestock mortality rates, and minimize production losses. This economic advantage is particularly important in large-scale farming operations, where disease outbreaks can result in substantial financial losses. The use of vaccines helps to stabilize farm income, enhance profitability, and ensure the sustainability of agricultural enterprises.
• Compliance with Trade Regulations: Vaccines are critical for meeting international trade regulations that require proof of vaccination for livestock and animal products. Many countries have stringent import and export regulations to prevent the spread of diseases across borders. Vaccination ensures that animals are free from specific diseases, allowing farmers to access global markets and participate in international trade. Compliance with these regulations not only supports the growth of the livestock industry but also helps to prevent the spread of animal diseases worldwide.

Conclusion

The veterinary vaccines market is poised for significant growth, driven by several key factors. Increasing awareness about animal health and welfare, coupled with rising pet ownership worldwide, has heightened the demand for vaccines. This growth is also propelled by technological advancements, such as the development of recombinant DNA vaccines, which offer enhanced efficacy and safety. Government initiatives promoting animal health further support market expansion, with regulatory bodies ensuring the safety and effectiveness of new vaccines. Additionally, the increasing prevalence of zoonotic diseases, which can transfer from animals to humans, emphasizes the importance of vaccines in maintaining public health. As a result, pharmaceutical companies are investing in research to develop vaccines that can prevent these diseases in animal populations​.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF